Monoclonal antibodies have emerged as a powerful weapon in the fight against a variety of diseases, including several types of cancer – but producing them remains a costly process. Crystallisation is the way forward, say EU-funded researchers working on an innovation that could make it easier, greener and far more affordable.

Source: Research Information Centre
A crystal-clear way to make crucial drugs more affordable